Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 18, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 19, 2026
DirectorIndirect holdingGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001753926-26-002205
Filed / recorded
Nov 19, 2026, 9:30 PM UTC
Added to OQRO
Nov 19, 2026, 9:35 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Vivani Medical, Inc.
Issuer CIK
1266806
Ticker
VANI
Reporting person
Aaron Mendelsohn
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Nov 18, 2026
Transaction code
A
Shares / units
99,010
Price per share
$1.01
Acquired / disposed
Disposed (D)
Shares owned after
997,327
Ownership form
Indirect — See footnote
Amendment
No
Footnotes from the filing
The reporting person purchased 99,010 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of November 15, 2026 at a price of $1.01 per share, which was the last reported sale price of the Issuers common stock on the Nasdaq on November 13, 2026 (the trading day immediately prior to November 15, 2026). The gross proceeds from this private sale transaction were $100,000.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
The reporting person owns 1,165,497 shares directly and/or indirectly as follows: (i) 168,170 shares of common stock owned by the reporting person, (ii) 150,930 shares in five trusts, each of which has been established for a separate grandchild of the Reporting Person, with each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority, (iii) 846,397 shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of MFE, LLC and therefore disclaims 169,279 shares of the 846,397 shares of common stock owned by MFE, LLC, which 169,279 shares are beneficially owned by other members of the limited liability company.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.